[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643192":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":12,"locations":25,"responsibleParty":141,"collaborators":143,"id":147,"slug":12,"hasResults":148,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":152,"eligibilityCriteria":153,"healthyVolunteers":148,"sex":154,"minAge":155,"maxAge":12,"enrollmentInfo":156,"targetDuration":12,"studyType":159,"phases":160,"briefSummary":162,"conditions":163,"keywords":166,"overallStatus":28,"whyStopped":12,"lastUpdateSubmitDate":174,"lastUpdatePostDateStruct":175,"startDateStruct":178,"completionDateStruct":180,"leadSponsor":182,"locationsCount":183},{"fullName":5,"class":6},"CareAcross","INDUSTRY",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","NO_INTERVENTION","Participants in this group utilize the personalized digital platform to record adverse events as Patient-Reported Outcomes (PROs). They only receive an acknowledgement of their submission.\n\nTheir standard clinical treatment and monitoring continue unaffected.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention","EXPERIMENTAL","Participants in this group utilize the personalized digital platform to record adverse events as Patient-Reported Outcomes (PROs). Additionally, they receive short textual personalized educational and supportive material online.\n\nTheir standard clinical treatment and monitoring continue unaffected.",[18],"Behavioral: Digital support",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","Digital support","Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.",[14],[26,44,54,64,71,81,89,99,108,121,131],{"facility":27,"status":28,"city":29,"state":12,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"401 General Military Hospital","RECRUITING","Athens","11525","Greece",{"type":33,"coordinates":34},"Point",[35,36],23.72784,37.98376,{"lat":36,"lon":35},[39],{"name":40,"role":41,"phone":42,"phoneExt":12,"email":43},"Investigator","CONTACT","+302107494009","mededu401@gmail.com",{"facility":45,"status":28,"city":29,"state":12,"zip":46,"country":31,"cosmosGeoPoint":47,"geoPoint":49,"contacts":50},"251 Air Force General Hospital","11527",{"type":33,"coordinates":48},[35,36],{"lat":36,"lon":35},[51],{"name":40,"role":41,"phone":52,"phoneExt":12,"email":53},"+302107463399","vivliothiki@251gna.gr",{"facility":55,"status":28,"city":29,"state":12,"zip":56,"country":31,"cosmosGeoPoint":57,"geoPoint":59,"contacts":60},"Attikon Hospital, 2nd clinic","12461",{"type":33,"coordinates":58},[35,36],{"lat":36,"lon":35},[61],{"name":40,"role":41,"phone":62,"phoneExt":12,"email":63},"+302105831000","politis@attikonhospital.gov.gr",{"facility":65,"status":28,"city":29,"state":12,"zip":56,"country":31,"cosmosGeoPoint":66,"geoPoint":68,"contacts":69},"Attikon Hospital, 4th clinic",{"type":33,"coordinates":67},[35,36],{"lat":36,"lon":35},[70],{"name":40,"role":41,"phone":62,"phoneExt":12,"email":63},{"facility":72,"status":28,"city":29,"state":12,"zip":73,"country":31,"cosmosGeoPoint":74,"geoPoint":76,"contacts":77},"Hygeia hospital","15123",{"type":33,"coordinates":75},[35,36],{"lat":36,"lon":35},[78],{"name":40,"role":41,"phone":79,"phoneExt":12,"email":80},"+302106867000","info@hygeia.gr",{"facility":82,"status":28,"city":29,"state":12,"zip":73,"country":31,"cosmosGeoPoint":83,"geoPoint":85,"contacts":86},"Mitera hospital",{"type":33,"coordinates":84},[35,36],{"lat":36,"lon":35},[87],{"name":40,"role":41,"phone":88,"phoneExt":12,"email":80},"+302106869000",{"facility":90,"status":28,"city":29,"state":12,"zip":91,"country":31,"cosmosGeoPoint":92,"geoPoint":94,"contacts":95},"Metropolitan General Hospital","15562",{"type":33,"coordinates":93},[35,36],{"lat":36,"lon":35},[96],{"name":40,"role":41,"phone":97,"phoneExt":12,"email":98},"+302106502000","info@metropolitan-general.gr",{"facility":100,"status":28,"city":29,"state":12,"zip":31,"country":31,"cosmosGeoPoint":101,"geoPoint":103,"contacts":104},"Ippokrateio General Hospital",{"type":33,"coordinates":102},[35,36],{"lat":36,"lon":35},[105],{"name":40,"role":41,"phone":106,"phoneExt":12,"email":107},"+302132088000","academic@hippocratio.gr",{"facility":109,"status":28,"city":110,"state":12,"zip":111,"country":31,"cosmosGeoPoint":112,"geoPoint":116,"contacts":117},"Bioclinic","Thessaloniki","54622",{"type":33,"coordinates":113},[114,115],22.93493,40.64072,{"lat":115,"lon":114},[118],{"name":40,"role":41,"phone":119,"phoneExt":12,"email":120},"+302310372600","the.bioclinic@bioclinic.gr",{"facility":122,"status":28,"city":110,"state":12,"zip":123,"country":31,"cosmosGeoPoint":124,"geoPoint":126,"contacts":127},"Ippokratio General Hospital of Thessaloniki","54642",{"type":33,"coordinates":125},[114,115],{"lat":115,"lon":114},[128],{"name":40,"role":41,"phone":129,"phoneExt":12,"email":130},"+302313312000","manager@ippokratio.gr",{"facility":132,"status":28,"city":110,"state":12,"zip":133,"country":31,"cosmosGeoPoint":134,"geoPoint":136,"contacts":137},"Papageorgiou General Hospital","56403",{"type":33,"coordinates":135},[114,115],{"lat":115,"lon":114},[138],{"name":40,"role":41,"phone":139,"phoneExt":12,"email":140},"+302313323000","kep@papageorgiou-hospital.gr",{"type":142,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[144],{"name":145,"class":146},"Hellenic Group of Sarcomas & Rare Cancers (HGSRC)","UNKNOWN","100643192",false,"NCT07642375","Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients","Observational, Randomized, Prospective Study of the Impact of Digital Health Interventions on Symptom and Side-Effect Management in Patients With Metastatic Sarcoma","SARC-Digital","Inclusion Criteria:\n\n* Age of ≥ 18 years.\n* Diagnosis of locally advanced or metastatic sarcoma of any location and origin.\n* Ability to understand and operate in a digital environment.\n* Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.\n* Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.\n\nExclusion Criteria:\n\n* Limited ability or willingness to report side-effects on an online platform.\n* Performance status \\>3.\n* Life expectancy of \\\u003C6 months.\n* Participation in an interventional clinical trial with investigational drugs or devices.","ALL","18 Years",{"count":157,"type":158},108,"ESTIMATED","INTERVENTIONAL",[161],"NA","The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.",[164,165],"Advanced Sarcoma","Metastatic Sarcoma",[167,168,169,170,171,172,173],"digital oncology","quality of life","qol","patient reported outcomes","PRO","supportive care","digital therapeutics","2026-06-07",{"date":176,"type":177},"2026-06-11","ACTUAL",{"date":179,"type":177},"2023-08-22",{"date":181,"type":158},"2027-02",{"name":5,"class":6},11]